Home LiteratureArticle Details
PMID: 3662471 Published · ppublish English Comparative Study Journal Article

Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 7 ·1987-07-00 ·Pages 1075-8

Barriere SL, Kaatz GW, Schaberg DR, Fekety R

Abstract

The pharmacokinetic disposition of vancomycin and ciprofloxacin was assessed in rabbits before the efficacy of these compounds in experimental staphylococcal endocarditis was compared. Ciprofloxacin was given in single intravenous bolus doses of 25 and 35 mg/kg and also in a multiple-dose regimen of 35 mg/kg every 6 h. Vancomycin was given in a similar manner in single doses of 17.5 and 25 mg/kg and in a multiple-dose regimen of 17.5 mg/kg every 6 h. Serum was sampled frequently after injections and analyzed by microbiologic assay for drug concentration. The pharmacokinetic parameters of clearance and steady-state volume of distribution were calculated by compartment-independent methods. These studies revealed that clearance of ciprofloxacin was reduced significantly after multiple doses (7.42 +/- 0.85 [standard deviation] versus 6.09 +/- 0.71 liters/h, P less than 0.01). Although the half-life and volume of distribution increased after multiple dosing, the differences were not statistically significant. The disposition of vancomycin following single doses was significantly altered after the 25-mg/kg dose compared with the 17.5-mg/kg dose. Half-life, clearance, and volume of distribution changed from 1.27 +/- 0.2 to 1.60 +/- 0.21 h (P less than 0.05), 0.54 +/- 0.05 to 0.39 +/- 0.04 liters/h (P less than 0.01), and 0.37 +/- 0.04 to 0.31 +/- 0.03 liters/kg (P less than 0.05), respectively. The disposition of ciprofloxacin was not altered with increases in dose size, and the disposition of vancomycin was not altered after multiple doses. If such alterations in the pharmacokinetic disposition of antimicrobial agents are unanticipated, the higher and more prolonged than expected serum concentrations may have an effect on the outcome of experimental infections.

MeSH Terms
Animals Ciprofloxacin/administration & dosage,metabolism Injections, Intravenous Kinetics Male Rabbits Vancomycin/administration & dosage,metabolism
Chemicals
Ciprofloxacin Vancomycin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Barriere S L
Department of Pharmaceutical Services, University of California, Los Angeles 90024.
Kaatz G W
Schaberg D R
Fekety R
References (16)
16 references, click to expand
  1. Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.
    J Lab Clin Med. 1971 Sep;78(3):457-63 PMID: 4999161
  2. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Sep;30(3):382-4 PMID: 3640590
  3. In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
    J Antimicrob Chemother. 1984 Apr;13(4):333-46 PMID: 6233250
  4. Multiple-dose ciprofloxacin kinetics in normal subjects.
    Clin Pharmacol Ther. 1984 Sep;36(3):384-8 PMID: 6467798
  5. Pharmacokinetics of intravenously administered ciprofloxacin.
    Antimicrob Agents Chemother. 1984 Aug;26(2):208-10 PMID: 6486762
  6. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    J Infect Dis. 1985 Jan;151(1):157-65 PMID: 3965588
  7. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):757-61 PMID: 6517559
  8. Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    J Infect Dis. 1985 Feb;151(2):291-4 PMID: 3155780
  9. Multiple-dose ciprofloxacin dose ranging and kinetics.
    Clin Pharmacol Ther. 1985 Jun;37(6):633-7 PMID: 3159530
  10. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  11. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
    J Infect Dis. 1986 Apr;153(4):707-14 PMID: 2936832
  12. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.
    Antimicrob Agents Chemother. 1986 Feb;29(2):298-302 PMID: 2940965
  13. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1986 Mar;29(3):461-3 PMID: 3459391
  14. Tissue penetration of ciprofloxacin after single and multiple doses.
    Antimicrob Agents Chemother. 1986 Mar;29(3):501-5 PMID: 2940974
  15. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins.
    J Infect Dis. 1986 Sep;154(3):511-7 PMID: 3734494
  16. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Antimicrob Agents Chemother. 1980 Feb;17(2):280-5 PMID: 7387148
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-07-00
Pages
1075-8
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC174874
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]